BioLineRx (BLRX) Gross Profit (2010 - 2026)
BioLineRx (BLRX) posted Gross Profit of $235,000 for the quarter ended Jun 30, 2026, up 1.3% from $232,000 a year earlier but down 38.5% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Gross Profit (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at BioLineRx was $1.11 million, down 89.1% year-over-year; for the year ended Dec 31, 2025, it was $950,000, down 95.2% from the prior year.
- In prior years, BioLineRx's Gross Profit was $19.68 million in the year ended Dec 31, 2024 and $1.11 million in the year ended Dec 31, 2023.
- Quarterly Gross Profit has run from a low of $154,000 in the quarter ended Dec 31, 2025 to a high of $5.66 million in the quarter ended Dec 31, 2024 over five years.
- On a year-over-year basis, Gross Profit increased in two of the last six quarters, with an average decline of 50.9%.
- According to Business Quant data, Gross Profit for the three prior quarters was $382,000 (quarter ended Mar 31, 2026), $154,000 (quarter ended Dec 31, 2025) and $343,000 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn |
| 10 | BioLineRx | 8.67 Mn | -67.85 Mn | 235,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 235,000.00 |
| Mar 31, 2026 | 382,000.00 |
| Dec 31, 2025 | 154,000.00 |
| Sep 30, 2025 | 343,000.00 |
| Jun 30, 2025 | 232,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Dec 31, 2024 | 5.66 Mn |
| Sep 30, 2024 | 4.12 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Mar 31, 2024 | 5.40 Mn |
| Sep 30, 2010 | 23.10 Mn |
API Access
BioLineRx Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();